HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature
<p>Through the recent conduct of the ToGA trial, HER2 has shown to be predictive for the treatment with trastuzumab in advanced gastric and gastro-oesophageal cancer. When it comes to the prognostic properties the situation is different. Despite the fact that it is more than 20 years ago since...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ivyspring International Publisher
2012-01-01
|
| Series: | Journal of Cancer |
| Online Access: | http://www.jcancer.org/v03p0137.htm |